References
Bier A. Versuche uber cocainisirung des ruckenmarkes. Dtsch Z Chir 1899; 5151: 361.
Ready LB, Plumer MH, Haschke RH, Austin E, Sumi SM. Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology 1985; 63: 364–70.
Rigler ML, Drasner K, Krejcie TC, et al. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg 1991; 72: 275–81.
Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154–7.
Pollock JE. Transient neurological symptoms: etiology, risk factors, and management. Reg Anesth Pain Med 2002; 27: 581–6.
Beardsley D, Holman S, Gantt R, et al. Transient neurologic deficit after spinal anesthesia: local anesthetic maldistribution with pencil point needles? Anesth Analg 1995; 81: 314–20.
Rodriguez-Chinchilla R, Rodriguez-Pont A, Pintanel T, Vidal-Lopez F. Bilateral severe pain at L3-4 after spinal anaesthesia with hyperbaric 5% lignocaine. Br J Anaesth 1996; 76: 328–9.
Lewis WR, Perrino AC Jr. Transient neurological symptoms after subarachnoid meperidine. Anesth Analg 2002; 94: 213–14.
Hodgson PS, Neal JM, Pollock JE, Liu SS. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 1999; 88: 797–809.
Nishiyama T, Matsukawa T, Hanaoka K. Intrathecal propofol has analgesic effects on inflammation-induced pain in rats. Can J Anesth 2004; 51: 899–904.
Omote K, Iwasaki H, Kawamata M, Satoh O, Namiki A. Effects of verapamil on spinal anesthesia with local anesthetics. Anesth Analg 1995; 80: 444–8.
Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: a review. Anesth Analg 2003; 97: 1108–16.
Daugherty PM, Staats PS. Intrathecal drug therapy for chronic pain: from basic science to clinical practice. Anesthesiology 1999; 91: 1891–918.
Kohno T, Kumamoto E, Baba H, et al. Actions of midazolam on GABAergic transmission in substantia gelatinosa neurons of adult rat spinal cord slices. Anesthesiology 2000; 92: 507–15.
Bali M, Akabas MH. Defining the propofol binding site location on the GABAA receptor. Mol Pharmacol 2004; 65: 68–76.
van Hilten BJ, van de Beek WJ, Hoff JI, Voormolen JH, Delhaas EM. Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 2000; 343: 625–30.
Bharti N, Madan R, Mohanty PR, Kaul HL. Intrathecal midazolam added to bupivacaine improves the duration and quality of spinal anaesthesia. Acta Anaesthesiol Scand 2003; 47: 1101–5.
Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001; 32: 2099–109.
Yaksh TL, Allen JW. Preclinical insights into the implementation of intrathecal midazolam: a cautionary tale. Anesth Analg 2004; 98: 1509–11.
Coombs DW, Fratkin JD. Neurotoxicology of spinal agents. Anesthesiology 1987; 66: 724–6.
Yaksh TL, Collins JG. Studies in animals should precede human use of spinally administered drugs. Anesthesiology 1989; 70: 4–6.
Eisenach JC, Hood DD, Curry R. Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans. Anesthesiology 2002; 96: 24–8.
Hood DD, Eisenach JC, Tuttle R. Phase I safety assessment of intrathecal neostigmine methylsulfate in humans. Anesthesiology 1995; 82: 331–43.
Yaksh TL, Grafe MR, Malkmus S, Rathbun ML, Eisenach JC. Studies on the safety of chronically administered intrathecal neostigmine methylsulfate in rats and dogs. Anesthesiology 1995; 82: 412–27.
Hood DD, Eisenach JC, Tong C, Tommasi E, Yaksh TL. Cardiorespiratory and spinal cord blood flow effects of intrathecal neostigmine methylsulfate, clonidine, and their combination in sheep. Anesthesiology 1995; 82: 428–35.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Awad, I.T., Chan, V. Developing yet another spinal analgesic drug?. Can J Anesth 51, 871–874 (2004). https://doi.org/10.1007/BF03018882
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03018882